Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group

Meletios A Dimopoulos; C. Bakoyannis; Vassilis Georgoulias; Christos Papadimitriou; Lia A. Moulopoulos; C. Deliveliotis; A. Karayannis; Ioannis Varkarakis; Gerasimos Aravantinos; Anastasios Zervas; D Pantazopoulos; George Fountzilas; Aristotelis Bamias; Zacharias Kyriakakis; Αchilles Anagnostopoulos; Αθανάσιος Γιαννόπουλος; P. Kosmidis

doi:10.1023/a:1008379500436

Shared by

Meletios A Dimopoulos

Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group

Article 1999 en

Authors

Meletios A Dimopoulos
CB
C. Bakoyannis
VG
Vassilis Georgoulias

Related publications

Article2006

Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for frontline chemotherapy of advanced ovarian carcinoma (AOC): A Hellenic Cooperative Oncology Group Study

Gerasimos Aravantinos, George Fountzilas, Haralabos P. Kalofonos, D. Skarlos, P. Kosmidis, Irene Grimani, Nicholas Pavlidis, D. Bafaloukos, Dimitrios Pectasides, Meletios A Dimopoulos

Article2002

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group

Meletios A Dimopoulos, Christos Papadimitriou, K. Sarris, Gerasimos Aravantinos, Charalambos Kalofonos, Dimitra Gika, Georgios M. Gourgoulis, Eleni Efstathiou, Dimosthenis Skarlos, Dimitrios Bafaloukos

Article2004

Temozolomide and cisplatin (TP) vs temozolomide (T) in patients with advanced melanoma. A randomized phase II of the Hellenic Cooperative Oncology Group

Dimitrios Bafaloukos, Dimosthenis Tsoutsos, Haralabos P. Kalofonos, Meletios A Dimopoulos, E. Briassoulis, George Fountzilas, Aris Polyzos, D. Skarlos, V. Georgoulias, Helen Gogas

Article2004

Temozolomide and cisplatin (TP) vs temozolomide (T) in patients with advanced melanoma. A randomized phase II of the Hellenic Cooperative Oncology Group

D. Bafaloukos, Dimosthenis Tsoutsos, Haralabos P. Kalofonos, Meletios A Dimopoulos, E. Briassoulis, George Fountzilas, Aris Polyzos, D. Skarlos, V. Georgoulias, Helen Gogas

Article2007

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group

Dimitrios Pectasides, Epaminontas Samantas, George Fountzilas, Evangelos Briasoulis, P. Kosmidis, Dimosthenis Skarlos, Meletios A Dimopoulos, Haralabos P. Kalofonos, Theofanis Economopoulos, Konstantinos Syrigos

Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group

Discussion(0)

Related publications

Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for frontline chemotherapy of advanced ovarian carcinoma (AOC): A Hellenic Cooperative Oncology Group Study

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group

Temozolomide and cisplatin (TP) vs temozolomide (T) in patients with advanced melanoma. A randomized phase II of the Hellenic Cooperative Oncology Group

Temozolomide and cisplatin (TP) vs temozolomide (T) in patients with advanced melanoma. A randomized phase II of the Hellenic Cooperative Oncology Group

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group